Toxic epidermal necrolysis associated with combination therapy of spironolactone and torsemide. Journal of Pharmacovigilance and Drug Research, [S. l.], v. 1, n. 1, p. 19–21, 2020. Disponível em: https://test.jpadr.com/index.php/jpadr/article/view/7. Acesso em: 13 oct. 2026.